Granulocyte colony-stimulating factor given in addition to interferon- α to mobilize peripheral blood stem cells for autologous transplantation in chronic myeloid leukaemia

British Journal of Haematology

Volumn 99, Issue 3, 1997, Pages 678-684

  Archimbaud, E ^a   Michallet, M ^a   Philip, I ^b   Charrin, C ^a   Clapisson, G ^b   Belhabri, A ^a   Guilhot, F ^c   Stryckmans, P ^d   Adeleine, P ^e   Fiere D ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b CENTRE LÉON BÉRARD   (France)

^c University of Poitiers   (France)

^d JULES BORDET INSTITUTE   (Belgium)

^e HOSPICES CIVILS DE LYON   (France)

Author keywords

Autograft; Chronic myeloid leukaemia; Filgrastim; Interferon ; Therapy

Indexed keywords

BUSULFAN; RECOMBINANT ALPHA INTERFERON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; APHERESIS; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW CELL; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CYTOGENETICS; HUMAN; HUMAN CELL; HUMAN TISSUE; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; REMISSION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 9844267321     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.4483258.x     Document Type: Article

References (46)

1. Barnett, M.J., Eaves, C.J., Phillips, G.L., Gascoyne, R.D., Hogge, D.E., Horsman, D.E., Humphries, R.K., Klingemann, H.G., Lansdorp, P.M., Nantel, S.H., Reece, D.E., Sheperd, J.D., Spinelli, J.J., Sutherland, H.J. & Eaves, A.C. (1994) Autografting with cultural marrow in chronic myeloid leukemia: results of a pilot study. Blood, 84, 724-732.
2. Bedi, A., Griffin, C.A., Barber, J.P., Vala, M.S., Hawkins, A.L., Sharkis, S.J., Zehnbauer, B.A. & Jones, R.J. (1994) Growth factor-mediated terminal differentiation of chronic myeloid leukemia. Cancer Research, 54, 5535-5538.
3. Bensinger, W., Singer, J., Appelbaum, F., Lilleby, K., Longin, K., Rowley, S., Clarke, E., Clift, R., Hansen, J., Shields, T., Storb, R., Weaver, C., Weiden, P. & Buckner, C.D. (1995) Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood, 81, 3158-3163.
4. Bhatia, R. & McGlave, P.B. (1995) T lymphocytes cultured from chronic myelogenous leukemia bone marrow suppress autologous hematopoietic progenitors. Leukemia, 9, 1006-1012.
5. Bhatia, R., Wayner, E.A., McGlave, P.B. & Verfaillie, C.M. (1994) Interferon-α restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired β1 integrin receptor function. Journal of Clinical Investigation, 94, 384-391.
6. Bolwell, B.J., Fishleder, A., Andresen, S.W., Lichtin, A.E., Koo, A., Yanssens, T., Burwell, R., Baucco, P. & Green, R. (1993) G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment. Bone Marrow Transplantation, 12, 609-614.
7. Carella, A.M., Chimirri, F., Podesta, M., Pitto, A., Piaggio, G., Dejana, A., Lerma, E., Pollicardo, N., Vassallo, F., Soracco, M., Benvenuto, F., Valbonesi, M., Carlier, P., Vimercati, R., Prencipe, E., Gatti, A.M., Ferrara, R.A., Incagliato, M., Florio, G. & Frassoni, F. (1996) High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia. Bone Marrow Transplantation, 17, 201-205.
8. - cells during early hematopoietic recovery in accelerated and chronic phases of chronic myeloid leukemia. Journal of Hematotherapy, 3, 199-202.
9. Carella, A.M., Podesta, M., Frassoni, F., Raffo, M.R., Pollicardo, N., Pungolino, E., Vimercati, R., Sessarego, M., Parodi, C., Rabitti, C., Ferrero, R., Benvenuto, F., Figari, O., Carlier, P., Levcasic, G., Valbonesi, M., Vitale, V. Giordano, D., Pierluigi, D., Nati, S., Guerraçio, A., Rosso, C. & Saglio, G. (1993) Collection of 'normal' blood repopulating cells during early hematopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia. Bone Marrow Transplantation, 12, 267-271.
10. Carlo-Stella, C., Mangoni, L., Almici, C., Céaramatti, C., Cottafavi, L., Dotti, G.P. & Rizzoli, V. (1994a) Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide. Bone Marrow Transplantation, 14, 425-432.
11. Carlo-Stella, C., Mangoni, L., Piovani, G., Garau, D., Almici, C. & Rizzoli, V. (1994b) Identification of Philadelphia-negative granulocyte-macrophage colony-forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients. Blood, 83, 1373-1380.
12. Cervantes, F., Pierson, B.A., McGlave, P.B., Verfaillie, C.M. & Miller, J.S. (1996) Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture. Blood, 87, 2476-2485.
13. Chalmers, E.A., Franklin, I.M., Kelsey, S., Clarke, R., Sprout, A.M., Goldstone, A.H., Hepplestone, A., Watson, W., Sharp, S. & Tansey, P. (1994) Mobilisation of Ph-negative peripheral blood stem cells in CML with idarubicin and cytarabine. Bone Marrow Transplantation, 14, (Suppl. 3), S38-S41.
14. Chao, N.J., Schriber, J.R., Grimes, K., Long, G.D., Negrin, R.S., Raimondi, C.M., Horning, S.J., Brown, S.L., Miller, L. & Blume, K.G. (1993) Granulocyte colony-stimulating factor 'mobilized' peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood, 81, 2031-2035.
15. Chikkappa, G., Wang, G.J., Santella, D. & Pasquale, D. (1988) Granulocyte colony-stimulating factor (G-CSF) induces synthesis of alkaline phosphatase in neutrophilic granulocytes of chronic myelogenous leukemia patients. Leukemia Research, 12, 491-498.
16. Coleman, S., Fisher, J., Hoy, T., Burnett, A.K. & Lim, S.H. (1996) Autologous MHC-dependent leukaemia-reactive T lymphocytes in a patient with chronic myeloid leukaemia. Leukemia, 10, 483-487.
17. Coulombel, L., Kalousek, D.K., Eaves, C.J., Gupta, C.M. & Eaves, A.C. (1983) Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. New England Journal of Medicine, 308, 1493-1498.
18. de Fabritis, P., Amadori, S., Petti, M.C., Mancini, M., Montefusco, E., Picardi, A., Geiser, T., Campbell, K., Calabretta, B. & Mandelli, F. (1995) In vitro purging with BCR-ABL antisense oligodeoxy-nucleotides does not prevent haematologic reconstitution after autologous bone marrow transplantation. Leukemia, 9, 662-664.
19. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow transplantation. Blood, 83, 3068-3076.
20. Giralt, S., Escudier, S., Kantarjian, H., Deisseroth, A., Freireich, E.J., Andersson, B.S., O'Brien, S., Andreeff, M., Fischer, H., Cork, A., Hirsch-Ginsberg, C., Trujillo, J., Stass, S. & Champlin, R.E. (1993) Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation. New England Journal of Medicine, 329, 757-761.
21. Goldman, J.M., Gale, R.P., Horowitz, M.M., Biggs, J.C., Champlin, R.E., Gluckman, E., Hoffmann, R.G., Jacobsen, S.J., Marmont, A.M., McGlave, P.B., Messner, H.A., Rimm, A.A., Rozman, C., Speck, B., Tura, S., Weiner, R.S. & Bortin, M.M. (1988) Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk for relapse associated with T-cell depletion. Annals of Internal Medicine, 108, 806-814.
22. Goldman, J.M., Szydio, R., Horowitz, M.M., Gale, R.P., Ash, R.C., Atkinson, K., Dicke, K.A., Gluckman, E., Herzig, R., Marmont, A., Masaoka, T., McGlave, P.B., Messner, H., O'Reilly, R.J., Reiflers, J., Rimm, A.A., Speck, B., Veum-Stone, J.A., Wingard, J.R., Zwaan, F.E. & Bortin, M.M. (1993) Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood, 82, 2235-2238.
23. Johnson, R.J., Owen, R.G., Child, J.A., Morgan, G.J., Barnard, D.L., Dickinson, H., Ricketts, S., Rawstron, A., Evans, P., Woodhead, V., Major, K., Robinson, F. & Smith, G.M. (1996) Mobilization of Philadelphia-negative peripheral blood mononuclear cells in chronic myeloid leukaemia using hydroxyurea and G-CSF (filgrastim). British Journal of Haematology, 93, 863-868.
24. Kantarjian, H.M., Talpaz, M., Andersson, B., Khouri, I., Giralt, S., Rios, M.B., Champlin, R., Hester, J. & Deisseroth, A.B. (1994) High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia. Bone Marrow Transplantation, 14, 57-61.
25. Kantarjian, H.M., Talpaz, M., Hester, J., Feldman, E., Korbling, M., Liang, J., Rios, M.B., Smith, T.L., Calvert, L. & Deisseroth, A.B. (1995) Collection of peripheral-blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive-dose chemotherapy. Journal of Clinical Oncology, 13, 553-559.
26. Kantarjian, H.M., Talpaz, M., Kontoyiannis, D., Gutterman, J., Keating, M.J., Estey, E.H., O'Brien, S., Rios, M.B., Beran, M. & Deisseroth, A. (1992) Treatment of chronic myelogeneous leukemia in accelerated and blastic phases with daunorubicin, high dose cytarabine and granulocyte-macrophage colony-stimulating factor. Journal of Clinical Oncology, 10, 398-405.
27. Kuss, B.J., Sage, R.E., Shepperd, K.M., Hardingham, J. & Nicola, M. (1993) High dose hydroxyurea in collection of Philadelphia chromosome-negative stem cells in chronic myeloid leukemia. Leukemia and Lymphoma, 10, 73-78.
28. Lewalle, P., Hensel, N., Guimaraes, A., Couriel, D., Jiang, Y.Z., Mavroudis, D. & Barrett, A.J. (1996) Helper and cytotoxic lymphocyte responses to chronic myeloid leukaemia: implications for adoptive immunotherapy with T cells. British Journal of Haematology, 92, 587-594.
29. McGahon, A., Bissonnette, R., Schmidt, M., Cotter, K.M., Green, D.R. & Cotter, T.G. (1994) BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood, 83, 1179-1187.
30. McGlave, P.B., Bartsch, G., Anasetti, C., Ash, R., Beatty, P., Gajewski, J. & Kernan, N.A. (1993) Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program. Blood, 81, 543-550.
31. McGlave, R.B., De Fabritiis, P., Deisseroth, A., Goldman, J., Barnett, M., Reiffers, J., Simonsson, B., Carella, A. & Aeppli, D. (1994) Autologous transplant for chronic myelogenous leukaemia: results from eight transplant groups. Lancet, 343, 1486-1488.
32. Mehta, J., Mijovic, A., Powles, R., Pagliuca, A., Singhal, S., Czepulkowski, B., Swansbury, G.J., Treleaven, J. & Mufti, G.J. (1996a) Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemia. Bone Marrow Transplantation, 17, 25-29.
33. Mehta, J., Powles, R., Singhal, S., Swansbury, G.J., Millar, B., Shepherd, V., Bell, J., Min, T., Cabral, S. & Treleaven, J. (1996b) High-dose hydroxyurea and G-CSF to collect Philadelphia-negative cells in chronic myeloid leukemia: preliminary results. Leukemia and Lymphoma, 23, 107-111.
34. + chromosome cells in vitro by combined hyperthermia and other drugs (AZT, IFN-α, TNF and quercetin): its application to autologous bone marrow transplantation for CML. Experimental Hematology, 23, 444-452.
35. Pawelec, G., Rehbein, A., Schlotz, E. & da Silva, P. (1996) Cellular immune responses to autologous chronic myelogenous leukemia cells in vitro. Cancer Immunology and Immunotherapy, 42, 193-199.
36. Reiffers, J., Goldman, J., Meloni, G., Cahn, J.Y. & Gratwohl, A. (1994) Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Bone Marrow Transplantation, 14, 407-410.
37. Scheffold, C., Brandt, K., Johnston, V., Lefterova, P., Degen, B., Schontube, M., Huhn, D., Neubauer, A. & Schmidt-Wolf, I.G. (1995) Potential of autologous immunologic effector cells for bone marrow purging in patients with chronic myeloid leukemia. Bone Marrow Transplantation, 15, 33-39.
38. Sheridan, W.P., Begley, C.G., To, L.B., Grigg, A., Szer, J., Maher, D., Green, M.D., Rowlings, P.A., McGrath, K.M., Cebon, J., Dyson, P., Watson, D., Bayly, J., de Luca, E., Tomita, D., Hoffman, E., Morstyn, G. & Juttner, C.A. (1994) Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies. Bone Marrow Transplantation, 14, 105-111.
39. Silla, L.M.R., Pincus, S.M., Locker, J.D., Glover, J., Elder, E.M., Donnenberg, A.D., Nardi, N.B., Bryant, J., Ball, E.D. & Whiteside, T.L. (1996) Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl-positive targets. British Journal of Haematology, 93, 375-385.
40. Simonsson, B., Oberg, G., Killander, A., Bjoreman, M., Borkholm, M., Gahrton, G., Hast, R., Turesson, I., Uden, A.M. & Malm, C. (1993) Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenous leukemia. Stem Cells, 11, (Suppl. 3), 73-76.
41. + patients. Annals of Internal Medicine, 114, 532-538.
42. Talpaz, M., Kantarjian, H., Liang, J., Calvert, L., Hamer, J., Tibbits, P., Durett, A., Claxton, D., Giralt, S., Khouri, I., Przepiorka, D., Van Besien, K., Andersson, B., Mehra, R., Gajewski, J., Seong, D., Hester, J., Estey, E., Korbling, M., Pollicardo, N., Berenson, R., Heimfeld, S., Champlin, R. & Deisseroth, A.B. (1995) Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found alter autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cells. Blood, 85, 3257-3263.
43. Thomas, E.D. & Clift R.A. (1989) Indications for marrow transplantation in chronic myelogenous leukemia. Blood, 73, 861-864.
44. + cells. Blood, 84, 2930-2939.
45. Verfaillie, C.M., Bahtia, R., Miller, W., Mortari, F., Roy, V., Burger, S., McCullough, J., Stieglbauer, K., Dewald, G., Heimfeld, S., Miller, J.S. & McGlave, P.B. (1996) BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients. Blood, 87, 4770-4779.
46. Yuo, A., Kitagawa, S., Okabe, T., Urabe, A., Komatsu, Y., Itoh, S. & Takaku, F. (1987) Recombinant human granulocyte colony-stimulating factor repairs the abnormalities of neutrophils in patients with myelodysplastic syndromes and chronic myelogenous leukemia. Blood, 70, 404-411.